Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study
MS Journal, July 9, 2021 https://geneuro.ch/data/news/MSJ-July-21-Efficacy-and-safety-of-temelimab-in-multiple-sclerosis.pdf
Menu
MS Journal, July 9, 2021 https://geneuro.ch/data/news/MSJ-July-21-Efficacy-and-safety-of-temelimab-in-multiple-sclerosis.pdf
© 2024 GeNeuro SA
3, Chemin du Pré-Fleuri
CH-1228 Plan-les-Ouates
Geneva, Switzerland